Foresite Capital Management V, LLC

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 83% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Foresite Capital Management V, LLC's trades of Latigo Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Alumis Inc (ALMS)
Transaction date
Purchase
Price
31.40
Quantity 54,881 +24.4%
Value US$4,968,875
US Alumis Inc (ALMS)
Transaction date
Purchase
Price
346.80
Quantity 38,413 +13.4%
Value US$1,621,619
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-10
B Purchase
89,627 -39.0%
471.30
US$972,291 		89,627 -39.0% 471.30 US$972,291
2024-07-03 2024-07-01
US Alumis Inc (ALMS)
B Purchase
54,881 +24.4%
31.40
US$4,968,875 		54,881 +24.4% 31.40 US$4,968,875
2024-07-03 2024-07-01
US Alumis Inc (ALMS)
B Purchase
38,413 +13.4%
346.80
US$1,621,619 		38,413 +13.4% 346.80 US$1,621,619
2023-07-19 2023-07-17
B Purchase
176,550 +14.6%
2.97
US$524,354 		176,550 +14.6% 2.97 US$524,354
2023-07-19 2023-07-17
B Purchase
523,450 +14.6%
2.97
US$1,554,646 		523,450 +14.6% 2.97 US$1,554,646
2023-04-06 2023-04-05
B Purchase
773,952 +6.0%
1.50
US$1,160,928 		773,952 +6.0% 1.50 US$1,160,928
2023-01-03 2022-12-29
B Purchase
250,000 +26.1%
5.00
US$1,250,000 		250,000 +26.1% 5.00 US$1,250,000
2023-01-03 2022-12-29
B Purchase
250,000 +7.5%
5.00
US$1,250,000 		250,000 +7.5% 5.00 US$1,250,000
2022-12-05 2022-12-01
B Purchase
637,420 +5.2%
0.85
US$541,807 		637,420 +5.2% 0.85 US$541,807